Insight Molecular Diagnostics Inc. Joins JPM Week and BTIG Snowbird Investor Conferences

Reuters
01/08
<a href="https://laohu8.com/S/IMDX">Insight Molecular Diagnostics Inc.</a> Joins <a href="https://laohu8.com/S/JPM">JPM</a> Week and BTIG Snowbird Investor Conferences

Insight Molecular Diagnostics Inc. (iMDx) will participate in several investor conferences this winter. The company’s management team will hold one-on-one meetings at the LifeSci Advisors 15th Annual Corporate Access Event on January 12 in San Francisco, as well as additional investor meetings in San Francisco from January 12 to January 14 during "JPM Week." iMDx will also attend the BTIG 13th Annual Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, taking place from February 9 to 11 at Cliff Lodge in Snowbird, Utah.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9621595) on January 07, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10